Saturday, January 31, 2026
22.2 C
Bengaluru

Specially Designed Case Study based Modules for Pharma Marketing Professionals

DEPA 2.0 Workshop – Open to participants from all companies – Starting February 5th, 2022.

We can also conduct a customized workshop to address your company’s specific needs on dates and timelines convenient to you.

The 4- Module Workshop series will be moderated by Anup Soans with international and Indian faculty – Dr. Peter Velev, a medical doctor and pharma industry veteran, and Salil Kallianpur, pharma marketing veteran and digital brand coach.

Objective: More than digitalizing your product promotions, the case calls for building and engaging your brand community through digital solutions that create memorable customer experiences.

With the new normal emerging, the traditional Pharma commercial model needs to be relooked by exploring alternative channels of engagement, which offer opportunities to create value for customers.

Company-specific digital adoption workshops to experience how a brand can be promoted using the omnichannel approach with field force involvement.

Interactive Webinars extended with Virtual Event – 4 Modules – 2.0 hours each over 4 weeks.

Register Now – https://medicinman.net/depa20-request-payment-link/register-for-depa-2-0/

https://medicinman.net/depa20-request-payment-link/register-for-depa-2-0/

Hot this week

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead

The latest PharmaTrac report for December 2025 offers a...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Topics

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Zydus vs. Helsinn — What It Really Means for Indian Pharma

On December 24, 2025, the Delhi High Court delivered...

Worldclass Healthcare But Out of Reach for Most Indians?

When an eminent cardiologist like Dr. Sunil Chandy—former Director...

Managed Healthcare – Better Choice for India?

Managed care shifts healthcare from fragmented fee-for-service models to...
spot_img

Related Articles

spot_imgspot_img